China Tumor Embolization Market Landscape Report 2022: Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook – ResearchAndMarkets.com


DUBLIN–()–The “China Tumor Embolization Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook” report has been added to ResearchAndMarkets.com’s offering.

Why Buy This Report

  • First-ever syndicated report with robust insights from Interventional Radiologists
  • Helps in understanding the current market scenario of tumor embolization in China
  • Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
  • Valuable insights from demand side of the market
  • Keep up with the latest market trends and novel technologies

Identify key players, local players and emerging players in the market

  • Boston Scientific
  • Merit Medical
  • Terumo
  • Sirtex Medical
  • ABK Medical
  • BTG

Key Topics Covered:

RESEARCH PROCESS OVERVIEW

  • Detailed Research Methodology
  • Desk Research and Quantitative Research

EXECUTIVE SUMMARY

TUMOR EMBOLIZATION (TE) CHINA MARKET OVERVIEW

  • Market Background – What is the scope of the research?

I – HEALTHCARE INFRASTRUCTURE (PROVIDER)

  • Healthcare System
  • Cancer Care – By Hospital Types
  • Healthcare Structure – Challenges?

II – PROCEDURE INSIGHTS

  • Procedure Split by Cancer Type
  • Procedure Split by Specialist Type
  • Procedure Split by Techniques
  • Average Procedures By Physician
  • Procedure Growth Rates

III – BRAND PERCEPTION

  • Brand Perception (Interventionalists)
  • Best-in-Class Brands

IV – COMPETITIVE INTELLIGENCE

  • CI Snapshot
  • Key Competitor Activities
  • Product portfolio
  • Product Approval Overview
  • Clinical Trials Overview
  • Company Profile
  • Product Approvals
  • Clinical Trials
  • Partnerships, M&A, Collaborations
  • Key Market Activities
  • Major Adverse Events

V – HEALTHCARE POLICY (PAYER)

  • Medical Devices Regulatory Body
  • Regulatory Approval Pathway
  • Reimbursement landscape
  • Disease Screening and Awareness Programs
  • Health Insurance Coverage
  • Digital Health Policy

VI – CLINICAL INTELLIGENCE (PHYSICIAN)

  • Referral Pathway
  • Treatment Overview
  • Treatment Care Pathway
  • Treatment Guidelines
  • Interventional Therapies
  • Interventional Technology
  • Healthcare Specialists (who are the Performing Physicians)
  • Epidemiology

CONCLUSION

APPENDICES

For more information about this report visit https://www.researchandmarkets.com/r/wjrl04



Source link

The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

Leave a Reply

Back to top button